SLC25A28 and breast cancer: In order to ensure whether butyrate suppresses BC tumor growth by targeting TLR4-PDXK/SLC25A28 signalling pathway, T47D cells were transfected with the plasmid expressing TLR4 or empty plasmid, and simultaneously treated with 5.0 mM butyrate.